arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

Jaguar Health, Inc.

JAGX
$44.50 ▲ +41.94 (+1638.28%) at close
Healthcare ·Pharmaceutical Preparations ·USPharmaceutical Preparations
51 Visible periods
28 Metrics
Peer-ranked Benchmarks
Price Chart
9
Health
Poor
Bearish
auto_awesome

Analytical Summary

Jaguar Health, Inc. faces fundamental challenges. The fundamentals warrant careful consideration of downside risks.

Market Cap $36.0M
Dividend Yield
Revenue Growth -58.9%
Op. Margin None
ROIC None
FCF / Share $-6.60
Trailing P/E
Price / Book
FCF Yield
Debt / Equity
info Valuation on last close. End-of-day price, Sep 22, 2026.

51-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$1.23M
↓ -58.9%
Net Income Profit after all expenses
$-12.80M
↓ -23.0%
Operating Margin Operating profit as % of sales
50.2%
↑ +121.4% 0th
FCF / Share Free cash flow per share
$-6.60
↓ -101.1%
Long-Term Debt Long-term obligations
$10.77M
↓ -1.0%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability
0
Financial Health
5
Cash Quality
37

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 13 years · 51 quarters